“As physicians who care deeply about the health and safety of our patients and communities, we are appalled by Donald Trump's reckless decision to appoint Robert F. Kennedy Jr.," over 19,000 docs wrote.
Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.